Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Launched by JASPER A. SMITS · Sep 13, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a unique smoking cessation program designed specifically for adults who feel a high level of anxiety about bodily sensations, which can make it harder for them to quit smoking. The program will be offered at local YMCA locations and aims to see if this personalized approach is effective for people from different racial and ethnic backgrounds who want to stop smoking.
To be eligible for the trial, participants must be at least 18 years old, smoke at least five cigarettes a day, and have a high level of anxiety sensitivity. They should also be motivated to quit smoking and live within 50 miles of a participating YMCA. Those who join can expect support tailored to their needs, helping them overcome challenges related to smoking and anxiety. It’s important to note that individuals who exercise regularly or are currently receiving other smoking cessation help aren’t eligible for the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (age ≥ 18);
- • High Anxiety Sensitivity (≥5 on the Short Scale Anxiety Sensitivity Index \[SSASI\]);
- • Daily smoker, ≥5 cigarettes (including e-cigarettes, little cigars/cigarillos) for ≥1 year;
- • Motivated to quit smoking as evidenced by a score of ≥5 on a 0-10 Likert scale;
- • Body mass index \<40;
- • Medical clearance to participate.
- • Located near a participating YMCA site (within 50 miles)
- Exclusion Criteria:
- • Regular exercise defined as engaging in vigorous-intensity exercise for at least 75 minutes per week for the last 3 months
- • Receiving current intervention for smoking cessation.
- • Outstanding debt to the YMCA
- • Listed as a sex offender on the National Sex Offender Registry
About Jasper A. Smits
Jasper A. Smits is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a commitment to ethical standards and regulatory compliance, Jasper A. Smits collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of new therapies and interventions. Their comprehensive approach encompasses all phases of clinical trials, ensuring robust data collection and analysis, while prioritizing participant safety and well-being. Through their endeavors, Jasper A. Smits aims to contribute significantly to the evolving landscape of healthcare and therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Jasper Smits, PhD
Principal Investigator
University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported